[{"address1": "22722 29th Dr. SE", "address2": "Suite 100", "city": "Bothell", "state": "WA", "zip": "98021", "country": "United States", "phone": "604 210 2217", "website": "https://www.achievelifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.", "fullTimeEmployees": 25, "companyOfficers": [{"maxAge": 1, "name": "Dr. Richard A. B. Stewart", "age": 65, "title": "CEO & Executive Director", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 892132, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark K. Oki CPA", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 425244, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Craig  Donnelly", "title": "Chief Operations Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jerry  Wan", "age": 42, "title": "VP of Finance & Principal Accounting Officer", "yearBorn": 1982, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Erik  Atkisson", "age": 52, "title": "Chief Legal Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jaime  Xinos", "age": 47, "title": "Chief Commercial Officer", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark L. Rubinstein", "title": "Interim Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.oncogenex.com/index.cfm", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.58, "open": 4.45, "dayLow": 4.37, "dayHigh": 4.67, "regularMarketPreviousClose": 4.58, "regularMarketOpen": 4.45, "regularMarketDayLow": 4.37, "regularMarketDayHigh": 4.67, "payoutRatio": 0.0, "beta": 1.692, "forwardPE": -3.8086958, "volume": 427589, "regularMarketVolume": 427589, "averageVolume": 1524481, "averageVolume10days": 714950, "averageDailyVolume10Day": 714950, "bid": 4.37, "ask": 4.48, "bidSize": 8, "askSize": 8, "marketCap": 243811680, "fiftyTwoWeekLow": 1.84, "fiftyTwoWeekHigh": 5.78, "allTimeHigh": 1856250.0, "allTimeLow": 1.84, "fiftyDayAverage": 3.8214, "twoHundredDayAverage": 3.08165, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 195008864, "profitMargins": 0.0, "floatShares": 43259536, "sharesOutstanding": 53233988, "sharesShort": 6095362, "sharesShortPriorMonth": 4392420, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.1154, "heldPercentInsiders": 0.04291, "heldPercentInstitutions": 0.48629, "shortRatio": 3.16, "shortPercentOfFloat": 0.1349, "impliedSharesOutstanding": 55664764, "bookValue": 0.636, "priceToBook": 6.8867927, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -52346000, "trailingEps": -1.35, "forwardEps": -1.15, "lastSplitFactor": "1:20", "lastSplitDate": 1596153600, "enterpriseToEbitda": -3.742, "52WeekChange": 0.05288458, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 4.38, "targetHighPrice": 25.0, "targetLowPrice": 10.0, "targetMeanPrice": 15.5, "targetMedianPrice": 13.0, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 48114000, "totalCashPerShare": 0.904, "ebitda": -52110000, "totalDebt": 9958000, "quickRatio": 4.945, "currentRatio": 5.144, "debtToEquity": 29.624, "returnOnAssets": -0.65452003, "returnOnEquity": -1.61082, "freeCashflow": -21753000, "operatingCashflow": -40677000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ACHV", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1763167765, "regularMarketTime": 1763154002, "exchange": "NCM", "messageBoardId": "finmb_415241078", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.36681, "shortName": "Achieve Life Sciences, Inc.", "marketState": "CLOSED", "regularMarketPrice": 4.38, "postMarketChangePercent": -1.1415569, "postMarketPrice": 4.33, "postMarketChange": -0.05000019, "regularMarketChange": -0.2, "regularMarketDayRange": "4.37 - 4.67", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1524481, "fiftyTwoWeekLowChange": 2.54, "fiftyTwoWeekLowChangePercent": 1.3804348, "fiftyTwoWeekRange": "1.84 - 5.78", "fiftyTwoWeekHighChange": -1.4000001, "fiftyTwoWeekHighChangePercent": -0.24221455, "fiftyTwoWeekChangePercent": 5.288458, "dividendDate": 1596153600, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1762435800, "earningsCallTimestampEnd": 1762435800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.35, "epsForward": -1.15, "epsCurrentYear": -1.2675, "priceEpsCurrentYear": -3.4556212, "fiftyDayAverageChange": 0.5586002, "fiftyDayAverageChangePercent": 0.14617684, "twoHundredDayAverageChange": 1.2983501, "twoHundredDayAverageChangePercent": 0.42131653, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 813504600000, "longName": "Achieve Life Sciences, Inc.", "displayName": "Achieve Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]